News

Filter

Current filters:

Jazz Pharmaceuticals

1 to 9 of 96283 results

Innovative and orphan drugs to become more accessible in Russia

30-09-2014

The Russian Parliament (State Duma) plans to ease access to innovative and orphan drugs to the Russian…

PharmaceuticalRegulationResearchRussia

Biosimilars set to revolutionize global drug development industry

30-09-2014

Intellectual Property and Science business of Thomson Reuters today announced the release of Biosimilars:…

BiosimilarsBiotechnologyGlobalMarkets & MarketingResearch

Sanofi may build new plant in Russia

30-09-2014

French pharma major Sanof plans to build a new plant in Russia, which is expected to be located in the…

PharmaceuticalProductionRussiaSanofi

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

30-09-2014

Swedish drug developer Karolinska Development has appointed current board member Klaus Wilgenbus as chief…

BiotechnologyBoardroomKarolinska DevelopmentKlaus WilgenbusSweden

Jay Feingold appointed CMO at ADC Therapeutics amid large-scale hiring drive

Jay Feingold appointed CMO at ADC Therapeutics amid large-scale hiring drive

30-09-2014

Oncology drug development company focused on antibody drug conjugates targeting major cancers, ADC Therapeutics,…

ADC TherapeuticsBoardroomOncologyPharmaceuticalSwitzerland

Verona Pharma appoints Biresh Roy as chief financial officer

Verona Pharma appoints Biresh Roy as chief financial officer

30-09-2014

UK respiratory specialist Verona Pharma has appointed Biresh Roy as chief financial officer and member…

BoardroomPharmaceuticalRespiratory and PulmonaryUKVerona Pharma

Bristol-Myers Squibb updates on Opdivo regulatory milestones

30-09-2014

US pharma major Bristol-Myers Squibb has announced multiple regulatory milestones for Opdivo (nivolumab),…

Bristol-Myers SquibbEuropeOncologyOno PharmaceuticalOpdivoPharmaceuticalRegulationUSA

ESMO 2014: GSK reports 45% survival rate in Tafinlar trial

ESMO 2014: GSK reports 45% survival rate in Tafinlar trial

29-09-2014

UK pharma major GlaxoSmithKline presented data at the European Society for Medical Oncology’s congress…

DacarbazineGlaxoSmithKlineOncologyPharmaceuticalResearchTafinlarUK

1 to 9 of 96283 results

Back to top